The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McFadden, D. C.
Right arrow Articles by Casadevall, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McFadden, D. C.
Right arrow Articles by Casadevall, A.
The Journal of Immunology, 2004, 172: 3670-3677.
Copyright © 2004 by The American Association of Immunologists

Unexpected Diversity in the Fine Specificity of Monoclonal Antibodies That Use the Same V Region Gene to Glucuronoxylomannan of Cryptococcus neoformans1

Diane C. McFadden* and Arturo Casadevall2,*,{dagger}

* Department of Medicine, Division of Infectious Disease, and {dagger} Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461

Most mAbs to the capsular polysaccharide glucuronoxylomannan (GXM) of Cryptococcus neoformans are generated from the same VH and VL gene families. Prior Ab studies have assessed protective efficacy, Id structure and binding to capsular polysaccharides, and peptide mimetics. These data have been interpreted as indicating that most mAbs to GXM have the same specificity. A new approach to Ab specificity analysis was investigated that uses genetic manipulation to generate C. neoformans variants with structurally different capsules. C. neoformans mutants expressing GXM with defective O-acetylation were isolated and complemented by the C. neoformans gene CAS1, which is necessary for the O-acetylation of GXM. The mAbs exhibited differences in their binding to the GXM from these mutant strains, indicating previously unsuspected differences in specificity. Analysis of three closely related IgMs revealed that one (mAb 12A1) bound to an epitope that did not require O-acetylation, another (mAb 21D2) was inhibited by O-acetylation, and the third (mAb 13F1) recognized an O-acetylation-dependent conformational epitope. Furthermore, an IgG Ab (mAb 18B7) in clinical development retained binding to de-O-acetylated polysaccharide; however, greater binding was observed to O-acetylated GXM. Our findings suggest that microbial genetic techniques can provide a new approach for epitope mapping of polysaccharide-binding Abs and suggest that this method may applicable for studying the antigenic complexity of polysaccharide Ags in other capsulated microorganisms.




This article has been cited by other articles:


Home page
Eukaryot CellHome page
D. C. McFadden, B. C. Fries, F. Wang, and A. Casadevall
Capsule Structural Heterogeneity and Antigenic Variation in Cryptococcus neoformans
Eukaryot. Cell, August 1, 2007; 6(8): 1464 - 1473.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
M. E. Maxson, E. Dadachova, A. Casadevall, and O. Zaragoza
Radial Mass Density, Charge, and Epitope Distribution in the Cryptococcus neoformans Capsule
Eukaryot. Cell, January 1, 2007; 6(1): 95 - 109.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. C. McFadden, M. De Jesus, and A. Casadevall
The Physical Properties of the Capsular Polysaccharides from Cryptococcus neoformans Suggest Features for Capsule Construction
J. Biol. Chem., January 27, 2006; 281(4): 1868 - 1875.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.